Back to Search
DR. JORDAN MACKAY GRAFF MD
MD
Retina Specialist (Ophthalmology) Physician
NPI: 1952487829IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology Physician
Ophthalmology
Code: 207W00000X
41796(AZ)
Retina Specialist (Ophthalmology) PhysicianPrimary
Ophthalmology — Retina Specialist
Code: 207WX0107X
41796(AZ)
Education
UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Class of 2003
Research & Publications (20)
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.
PMID 18156609·J Antimicrob Chemother·2008
4-observational
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.
PMID 17474542·Int J Clin Pharmacol Ther·2007
4-observational
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
PMID 17916229·J Thromb Haemost·2007
2-rct
Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study.
PMID 17577465·Clin Ther·2007
3-trial
Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
PMID 17873238·J Clin Pharmacol·2007
2-rct
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents.
PMID 16149028·Semin Thromb Hemost·2005
8-other
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
PMID 16321613·Clin Pharmacol Ther·2005
3-trial
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
PMID 15183041·Thromb Res·2004
4-observational
Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
PMID 12386643·Clin Pharmacol Ther·2002
4-observational
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
PMID 19383915·Cancer Res·2009
8-other
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism.
PMID 19180189·PLoS Pathog·2009
7-preclinical
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
PMID 19002764·Cancer Causes Control·2009
8-other
Prevalence of developmental and behavioral disorders in a pediatric hospital.
PMID 19254983·Pediatrics·2009
8-other
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
PMID 19373123·Pharmacogenet Genomics·2009
8-other
In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography.
PMID 19503801·J Oncol·2009
8-other
Polysaccharides derived from Yamoa (Funtumia elastica) prime gammadelta T cells in vitro and enhance innate immune responses in vivo.
PMID 19671448·Int Immunopharmacol·2009
4-observational
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study.
PMID 18800232·Eur J Health Econ·2009
8-other
Depression of the photic after discharge of flash evoked potentials by physostigmine, carbaryl and propoxur, and the relationship to inhibition of brain cholinesterase.
PMID 17950890·Neurotoxicology·2008
7-preclinical
Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo.
PMID 18809571·Mol Cell Biol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 270 S CANDY LN
COTTONWOOD, AZ 86326 - Phone
- (480) 892-8400
Quick Facts
- NPI
- 1952487829
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile